Location History:
- Epinay sous Senart, FR (2009 - 2012)
- Combs la Ville, FR (2012 - 2013)
Company Filing History:
4 out of 27 
2 out of 4 
1 out of 26 
Years Active: 2009-2013
Title: Innovations of Gilles Borrelly: A Pioneer in Modified Therapeutic Polypeptides
Introduction: Gilles Borrelly, based in Epinay-sous-Senart, France, has made significant contributions to the field of biotechnology, particularly in the realm of modified therapeutic polypeptides. With a remarkable portfolio of seven patents, his work exemplifies innovation and dedication to advancing medical treatments.
Latest Patents: Among his latest patents are groundbreaking developments in the area of coagulation factor IX and erythropoietin polypeptides. The first patent focuses on modified coagulation factor IX polypeptides and their applications for treatment. This innovation includes methods for generating modified FIX polypeptides and pharmaceutical compositions designed for oral administration, providing new avenues for treatment using these modified polypeptides. The second patent addresses modified erythropoietin polypeptides, which are engineered to exhibit enhanced physical properties and therapeutic activities compared to their unmodified counterparts. This patent also includes nucleic acid molecules encoding these innovative polypeptides, along with methods of treatment and diagnosis utilizing them.
Career Highlights: Throughout his career, Gilles Borrelly has had a pivotal role in multiple research and development ventures. He has worked with prominent companies such as Hanall Biopharma Co., Ltd. and Creabilis Therapeutics S.p.a., contributing to various projects that push the boundaries of therapeutic polypeptide technology.
Collaborations: Collaboration has been vital to Gilles Borrelly's success. He has worked alongside esteemed colleagues like Thierry Guyon and Lila Drittanti, fostering an environment of creativity and innovation that enhances the potential for groundbreaking discoveries in the pharmaceutical arena.
Conclusion: Gilles Borrelly stands out as a leading inventor, significantly impacting the field of modified therapeutic polypeptides through his innovative patents and collaborations. His work continues to influence medical treatments and improve the quality of care for patients, establishing him as a key player in biopharmaceutical innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.